JBPHF
Price
$0.29
Change
-$0.07 (-19.44%)
Updated
Feb 20 closing price
Capitalization
481.36M
LXRX
Price
$0.90
Change
-$0.02 (-2.17%)
Updated
Jul 3 closing price
Capitalization
327.22M
25 days until earnings call
Interact to see
Advertisement

JBPHF vs LXRX

Header iconJBPHF vs LXRX Comparison
Open Charts JBPHF vs LXRXBanner chart's image
Jacobio Pharmaceuticals Group
Price$0.29
Change-$0.07 (-19.44%)
Volume$5K
Capitalization481.36M
Lexicon Pharmaceuticals
Price$0.90
Change-$0.02 (-2.17%)
Volume$1.65M
Capitalization327.22M
JBPHF vs LXRX Comparison Chart in %
Loading...
LXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JBPHF vs. LXRX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JBPHF is a Buy and LXRX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (JBPHF: $0.29 vs. LXRX: $0.90)
Brand notoriety: JBPHF and LXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: JBPHF: 100% vs. LXRX: 38%
Market capitalization -- JBPHF: $481.36M vs. LXRX: $327.22M
JBPHF [@Biotechnology] is valued at $481.36M. LXRX’s [@Biotechnology] market capitalization is $327.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JBPHF’s FA Score shows that 1 FA rating(s) are green whileLXRX’s FA Score has 1 green FA rating(s).

  • JBPHF’s FA Score: 1 green, 4 red.
  • LXRX’s FA Score: 1 green, 4 red.
According to our system of comparison, LXRX is a better buy in the long-term than JBPHF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LXRX’s TA Score shows that 4 TA indicator(s) are bullish.

  • LXRX’s TA Score: 4 bullish, 4 bearish.

Price Growth

JBPHF (@Biotechnology) experienced а 0.00% price change this week, while LXRX (@Biotechnology) price change was -3.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

LXRX is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JBPHF($481M) has a higher market cap than LXRX($327M). LXRX YTD gains are higher at: 22.004 vs. JBPHF (0.000).
JBPHFLXRXJBPHF / LXRX
Capitalization481M327M147%
EBITDAN/A-164.27M-
Gain YTD0.00022.004-
P/E RatioN/AN/A-
RevenueN/A31.2M-
Total CashN/A195M-
Total DebtN/A102M-
FUNDAMENTALS RATINGS
LXRX: Fundamental Ratings
LXRX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
22
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
JBPHFLXRX
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
N/A
Bearish Trend 4 days ago
89%
Momentum
ODDS (%)
N/A
Bullish Trend 4 days ago
84%
MACD
ODDS (%)
N/A
Bullish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
9%
Bearish Trend 4 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
7%
Bullish Trend 4 days ago
86%
Advances
ODDS (%)
N/A
Bullish Trend 11 days ago
84%
Declines
ODDS (%)
N/A
Bearish Trend 21 days ago
88%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
86%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
LXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MFCAX40.280.39
+0.98%
Meridian Contrarian A
WCPIX54.020.43
+0.80%
Communication Services UltraSectorProInv
HSMYX13.140.09
+0.69%
Hartford Small Cap Value Y
TRVHX18.380.10
+0.55%
Nuveen Mid Cap Value I
AEIYX8.800.02
+0.23%
American Century Equity Income Y

JBPHF and

Correlation & Price change

A.I.dvisor indicates that over the last year, JBPHF has been closely correlated with RAPT. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if JBPHF jumps, then RAPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JBPHF
1D Price
Change %
JBPHF100%
N/A
RAPT - JBPHF
79%
Closely correlated
+0.50%
AXSM - JBPHF
32%
Poorly correlated
+1.47%
PYPD - JBPHF
23%
Poorly correlated
+0.29%
LXRX - JBPHF
21%
Poorly correlated
-1.63%
TNYA - JBPHF
20%
Poorly correlated
N/A
More

LXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, LXRX has been loosely correlated with PLRX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if LXRX jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LXRX
1D Price
Change %
LXRX100%
-1.63%
PLRX - LXRX
41%
Loosely correlated
+5.00%
ABOS - LXRX
39%
Loosely correlated
+2.65%
OCUL - LXRX
38%
Loosely correlated
+1.69%
RAPP - LXRX
37%
Loosely correlated
+2.03%
VCYT - LXRX
37%
Loosely correlated
N/A
More